Zydus Lifesciences Acquires 85.6% of Amplitude Surgical and Launches Mandatory Tender Offer
March 11, 2025
Zydus Lifesciences Limited entered into exclusive negotiations to buy a controlling 85.6% stake in Amplitude Surgical, valuing the block at €256.8 million (€6.25 per share), from PAI Partners and certain minority shareholders. After regulatory conditions were fulfilled, the 85.6% stake was completed, and Zydus will file (and then conduct) a simplified mandatory tender offer for the remaining shares at the same €6.25 price, followed by a squeeze-out to delist.
- Buyers
- Zydus Lifesciences Limited
- Targets
- Amplitude Surgical
- Sellers
- PAI Partners, Amplitude Surgical management, Two minority shareholders (names not specified)
- Industry
- Medical Devices
- Location
- France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Stryker Acquires Amplitude Vascular Systems (AVS) to Add Next-Generation IVL Technology
May 19, 2026
Medical Devices
Stryker completed its acquisition of Amplitude Vascular Systems, a privately held medical device company developing a next-generation intravascular lithotripsy (IVL) platform for calcified peripheral arterial disease (PAD). The deal was announced April 13, 2026 and closed May 7, 2026; financial terms were not disclosed in the MedDeviceGuide account, though other sources cite a value of up to $835 million.
-
Zydus Worldwide DMCC to Acquire Assertio Holdings in All-Cash $166.4 Million Tender Offer
May 13, 2026
Biotechnology
Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Limited, has entered into a definitive agreement to acquire all outstanding shares of Assertio Holdings, Inc. for $23.50 per share in cash, valuing the deal at approximately $166.4 million. The transaction is structured as a tender offer followed by a second-step merger at the same price and is expected to close in the second quarter of 2026 (2026–27 financial year in some reports), subject to customary conditions.
-
Novartis to Acquire MorphoSys in $2.9 Billion Deal
February 7, 2024
Pharmaceuticals
Novartis agreed to a voluntary public takeover offer to acquire MorphoSys AG for €68 per share, valuing the deal at about €2.7 billion (reported as $2.9 billion). The acquisition is intended to expand and complement Novartis’ oncology pipeline, including pelabresib (CPI-0610) and tulmimetostat (CPI-0209).
-
Surgical Notes Acquires Zulu Health
August 6, 2021
Healthcare Services
Surgical Notes has acquired Zulu Health, a Los Angeles-based revenue cycle management (RCM) provider focused on ambulatory surgery centers (ASCs). The deal brings Zulu Health's leadership and RCM capabilities into Surgical Notes (a CapStreet Group portfolio company) to expand and strengthen ASC-focused RCM services nationwide.
-
Zimmer Biomet Acquires A&E Medical Corporation
December 1, 2020
Medical Devices
Zimmer Biomet completed the acquisition of A&E Medical Corporation from private equity owner Vance Street Capital for $250 million. A&E Medical, headquartered in Farmingdale, New Jersey, is a designer and manufacturer of sternal closure systems, cardiac pacing wires and related disposable surgical products; the deal expands Zimmer Biomet's capabilities and product portfolio in cardiovascular and cardiothoracic surgical devices.
-
PAI Partners Agrees to Acquire Majority Stake in Amplitude Surgical
July 30, 2020
Medical Devices
PAI Partners has entered into exclusive negotiations to acquire a majority stake in Amplitude Surgical from Apax Partners and certain managers via an SPV, at a price of €2.15 per share, with a subsequent mandatory public tender offer planned. The transaction preserves existing management involvement and is intended to support Amplitude Surgical's continued international expansion and product development in lower-limb orthopedics.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.